对于学前注意力缺陷/多动性障碍的刺激剂反应的调节者
Luis C Farhat1, Luisa Shiguemi Sugaya2, Michael H Bloch3
1Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil; School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom.
与黑人儿童相比,对于患有注意力缺陷/多动障碍 (ADHD) 的白人儿童,兴奋剂可能更有效. 种族,而不是年龄或症状严重程度,可能会影响ADHD学龄前儿童的兴奋剂有效性.
科学领域:
- 儿科精神病学 儿科精神病学
- 神经发育障碍 神经发育障碍
- 药理疗法 药理疗法 药理疗法
背景情况:
- 注意缺陷/多动障碍 (ADHD) 是一个常见的神经发育障碍在学龄前儿童.
- 刺激药物经常被处方用于ADHD,但个体反应可能有所不同.
- 识别治疗疗效的调节者对于个性化医疗至关重要.
研究的目的:
- 确定预测ADHD学龄前儿童兴奋剂药物与安慰剂疗效的因素.
- 为被诊断患有多动症的幼儿提供个性化治疗建议.
主要方法:
- 分析了来自两个随机的安慰剂受控试验 (MAPPA和SPD489-347) 的个人参与者数据.
- 评估了基线人口和临床特征对ADHD症状严重性的调节效应.
- 在可能的情况下,元分析从附加研究 (PATS) 中汇集了子组数据.
主要成果:
- 在美国的研究中,与黑人儿童相比,白人儿童的兴奋剂疗效更大.
- 年龄较大并没有降低兴奋剂的有效性,也没有与更糟糕的结局有关.
- 较高的基线ADHD症状严重程度预测了更大的终点严重程度,无论治疗方法如何.
结论:
- 种族似乎是学前ADHD兴奋剂有效性的潜在调节者.
- 在本分析中,年龄和基线症状严重程度并不是显著的调节因素.
- 这些发现是探索性的,需要在未来的研究中得到确认.
更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
相关概念视频
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
